Related Experiment Video
Updated: Sep 11, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates
Miki Maeda1, Hiroaki Saito1,2,3, Amy B P Ribet2,3
1Molecular Skeletal Biology Laboratory, Department of Orthopedics and Trauma Surgery, University Medical Center Hamburg-Eppendorf, D-20251 Hamburg, Germany.
Abstract:
Bone remodeling is a dynamic process regulated by the activities of osteoclasts and osteoblasts. Imbalances in this process can lead to osteoporosis, a condition characterized by low bone mass and increased fracture risk. The homeodomain protein TG-interacting factor 1 (Tgif1) has been previously identified as a key regulator of osteoblast function. Here, we investigate the cell-autonomous role of Tgif1 in osteoclasts. Our findings reveal that Tgif1 is expressed in osteoclast precursors, with its expression increasing during RANKL and M-CSF-induced differentiation. Deletion of Tgif1 in the osteoclast lineage impairs osteoclast differentiation and resorption capacity, reducing aging-related bone loss in mice in vivo. Mechanistically, Tgif1 restricts ERK1/2 dephosphorylation by suppressing protein phosphatase 2A (PP2A), an ERK1/2 phosphatase. Inhibition of PP2A restores impaired differentiation of Tgif1-deficient osteoclasts, confirming its involvement in this process. These findings establish Tgif1 as an important regulator of osteoclast differentiation, function, and bone resorption, offering new insights into molecular mechanisms controlling bone mass maintenance.
Insights
TG-interacting factor 1 (Tgif1) is crucial for osteoclast function. Deleting Tgif1 impairs bone resorption and reduces bone loss, revealing its role in maintaining bone mass.
Area of Science:
- Cell Biology
- Molecular Biology
- Bone Biology
Background:
- Bone remodeling relies on osteoclasts and osteoblasts; imbalances cause osteoporosis.
- TG-interacting factor 1 (Tgif1) is known to regulate osteoblast function.
Purpose of the Study:
- To investigate the cell-autonomous role of Tgif1 in osteoclasts.
- To understand Tgif1's impact on osteoclast differentiation and function.
Main Methods:
- Examined Tgif1 expression during osteoclast differentiation.
- Utilized genetic deletion of Tgif1 in osteoclast lineage in mice.
- Investigated the molecular mechanism involving ERK1/2 and protein phosphatase 2A (PP2A).
Main Results:
- Tgif1 expression increases during osteoclast differentiation.
- Osteoclast-specific Tgif1 deletion impairs differentiation and bone resorption.
- Tgif1 deficiency reduces aging-related bone loss in mice.
- Tgif1 suppresses PP2A, a key ERK1/2 phosphatase.
- PP2A inhibition rescues Tgif1-deficient osteoclast differentiation.
Conclusions:
- Tgif1 is a critical regulator of osteoclast differentiation and function.
- Tgif1 plays a cell-autonomous role in controlling bone resorption.
- Tgif1's mechanism involves regulating PP2A activity.
- Tgif1 represents a potential therapeutic target for bone loss disorders.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
PI3K/mTOR/AKT Signaling Pathway

